14min chapter

Open to Debate cover image

Psychedelics for Mental Health: Help or Hype?

Open to Debate

CHAPTER

Navigating Psychedelic Medicine: The FDA's Breakthrough Designation

This chapter explores the FDA's breakthrough therapy designation and its significance for psychedelic treatments like LSD, psilocybin, and MDMA in mental health. The discussion touches on the need for responsible research, public perception, and the implications of recent policy decisions, including a vote in Massachusetts regarding psychedelic legalization. It concludes by advocating for careful regulation and further research to understand the potential benefits and risks associated with psychedelic therapies.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode